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ABSTRACT

Cancer is becoming one the leading causes of death worldwide, and in particular,
breast cancer, which is the second highest cause of cancer death for women.
Approximately 12 percent of US women will develop invasive breast cancer, and about
40,000 of US women will die from breast cancer in 2015. With better detection and
treatment options, breast cancer death has been decreasing over the past two decades.
Despite declining rates in breast cancer death, cancer progression is not well understood.
There are many studies focused on cancer, but in situ cancer studies are often hard to
reproduce and can even be impractical. There is a demand for in vitro cancer models that
imitate the in vivo environment of cancerous cells and tumor development.
Numerous models have been developed to better understand normal and
cancerous breast tissue. Tissue engineering involves the generation of three-dimensional
(3D) tissue structures by seeding cells onto a scaffold so the cells can attach and
proliferate into a 3D functional tissue. Unfortunately this approach lacks precise cellular
placement and fails to create the intricate and complex environment of normal human
tissue. The specific microenvironment has been shown to play a key role in metastatic
cell behavior and in determining phenotype and function of mammary cells. Design of a
particular 3D arrangement of cells would allow a better understanding of cellular
behavior and interactions.
One promising technique for tissue formation is biofabrication, which can
generate 3D tissues through the delivery of cells and biomaterials layer-by-layer.
Biofabrication can precisely arrange cells and create scaffolds with more organization
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and complexity. Bioprinting is the drop-by-drop deposition of cells and biomaterials.
Inkjet printing technology has been used to create bioprinters and is an inexpensive way
to print precise patterns of cell and biomaterials with little reduction in cellular viability,
with easy pattern modification, and with minimal effect on the substrate. Inkjet
bioprinting has great potential for the development of in vitro breast tissue models; the
general aim of this thesis was to test the capabilities of inkjet bioprinting for creating in
vitro cancer models.
The objective of this work was to characterize the interactions of cancerous and
noncancerous breast cells through several qualitative and quantitative methods after the
cells were printed into lines of varying distances apart, using a modified inkjet printer as
a bioprinter. MCF-10a and MCF-7 cells were printed into two opposing lines of varying
distances apart onto a collagen coated glass slide, using a bioprinter. To assess the effect
of the distance on printed lines of cancer and noncancerous breast cells, several testing
methods were proposed, and samples were taken at time points of Day 1 and Day 5 after
printing.
The results from the collected data lead to several general, key findings. First, the
cancerous cells modified the cellular behavior of the noncancerous cells. Second, time
played a key role in the performance of the cells, particularly for metabolic activity, and
the overall results points towards a change in cellular behavior with a change in distance
between lines. Last, the study laid the foundation for potential research to use a bioprinter
for in vitro cancer models. Future studies should focus on improvements or alterations to
the bioprinter and experimental analyses to enhance findings.
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CHAPTER ONE
LITERATURE REVIEW
Breast Cancer Statistics
Cancer is becoming one the leading causes of death worldwide with the US
spending over $100 billion in cancer care [1, 2]. In particular, breast cancer is the second
highest cause of cancer death for women [1, 3]. Approximately 12 percent of US women
will have invasive breast cancer, and about 40,000 of US women will die of breast cancer
in 2015. Fortunately, breast cancer death has been decreasing over the last two decades,
due to better detection and treatment [1]. Despite declining rates in breast cancer death,
more research is needed to further knowledge of cancer development and metastasis.
There are many studies focused on cancer, but in situ cancer studies are often hard to
reproduce and can even be impractical [1]. There is a demand for in vitro cancer models
that imitate the environment of cancerous cells and tumor development [3].

Normal and Cancerous Breast Tissue Models
Numerous models have been developed to better understand normal breast cell
function and tumor formation and development. Studies have investigated the molecular
mechanisms, the effect of the microenvironment on cellular behavior, and cancerous
versus normal cell function [4]. A model system should mimic select natural in vivo
conditions of breast tissue; the cell types, scaffold, and microenvironment factors are
important in model selection [5]. Normal tissues have a complex extracellular matrix
(ECM), with a microenvironment that involves hormones, growth factors, and adhesion
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molecules [6]. The specific microenvironment has been shown to play a key role in
metastatic cell morphology, and ECM can determine phenotype and function of
mammary cells [7, 9-10].
Two-dimensional (2-D) models have been used to understand the basic functions
of cellular formation and pathology of breast cells [5-6]. Two-dimensional in vitro
systems can be designed to study specific cellular function topics such as cellular growth,
differentiation, cell-cell interaction, and gene expression [8-9]. Though 2D culture
systems have been used to study breast cancer, 2D models are limited in the reproduction
of the in vivo environment and have been shown to provide different information than
three-dimensional (3-D) systems [7, 12-13]. Three-dimensional test systems provide the
opportunity to combine multiple cell types with a more complex microenvironment that
better resembles the in vivo condition [13]. Though 3D models offer great research
opportunity, conventional 3D models are limited by cell placement, reproducibility,
control of pore dimensions and distribution, and methods of data collection [14].
Traditional 3D tissue models are usually constructed by building a scaffold as a
support structure, and then seeding cells onto the scaffold; subsequently, the cells grow
and proliferate on the scaffold [5, 14-16]. However, this approach lacks precise cells
placement, and fails to meet the intricate environment of human tissue [14, 16]. Twodimensional and 3D tissue models are useful for biological studies and clinical
applications, but there are many challenges in forming a tissue model, due to the
complexity of living tissues [17].
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Both 2D and 3D model systems have been used to study intercellular signaling.
Intercellular signaling is an important aspect for understanding many complex biological
processes, and studying intercellular signaling can lead to a better understanding of
biological behavior [18]. In vivo settings are very intricate and complex, yet many
cellular tissue models have an imprecise, often random, arrangement of cells [18]. The
scaffold material and design is known to influence cells, and random cellular placement
can change the cell behavior [5]. The precise arrangement of cells for a model system
would allow a better understanding of cellular behavior and interactions and has great
potential in facilitating the study of cell-cell communication [19].

Bioprinting
One promising technique for biofabrication, i.e. precision tissue formation, is
bioprinting. Biofabrication is the biomedical application for additive manufacturing [5,
14] and bioprinting is a specific technology for drop-by-drop deposition. Additive
manufacturing is the creation of 3D structures by layer-by-layer construction [5].
Biofabrication can generate 3D tissues through the delivery of cells and biomaterials
layer-by-layer [5, 14, 16-18]. Bioprinting involves the precise arrangement of cells on a
drop-by-drop basis, making the process of creating living tissue more quantitative [18].
Hence bioprinting can facilitate the production of scaffolds with more structural integrity,
organization, and complexity [16]. Other potential applications for bioprinting include
cell-based sensors, drug screens, and tissue and tumor models [5].
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Biofabrication Technologies
Multiple technologies could potentially be used to produce a specific arrangement
of cells for in vitro models [18]. Inkjet printing, extrusion bioprinting, and laser assisted
bioprinting are a few examples [5, 14, 18]. Inkjet printing can be used to pattern
biomaterials and cells; previous studies have begun to identify the effects of the printing
on cell viability [5, 10, 21-22]. Inkjet printing needs a low viscosity bioink for drop
ejection [5], where bioink is defined as the mixture of cells and biomaterials used for
bioprinting [14]. Laser-based bioprinters can precisely place cells in a very small 3D
structure [14, 18]. Since laser-based bioprinters do not involve nozzles, a bioink with
high viscosity can be printed with a higher degree of precision. However, the heat of the
laser-based bioprinter can damage the cells and affect cellular behavior, and the laser
methods require cells to be embedded in gels [5, 14]. Extrusion-based technology has
also been suggested. Extrusion-based approaches can produce constructs with better
mechanical and structural strength and can be used in conjunction with computer-aided
design programs to plan structures [14, 18]. Though extrusion methods have a wider
range of fluid properties, the high shear stress of extrusion-based bioprinting can reduce
cell viability and result in a lower resolution output [5, 14].

Inkjet Bioprinting
Inkjet printing technology has great potential for bioprinting. Inkjet printing
allows printing of precise patterns of cell and biomaterials in a controlled manner with
minimal effect on the samples [5, 19]. Inkjet technology originated in the 1980s with the
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emersion of the first personal computer [14, 16]. Inkjet printers were first used as
bioprinters in the early 2000s, when ink was replaced with bioink [14]. There are two
types of inkjet printers, thermal and piezoelectric [14]. Thermal inkjet printers supply a
pulse to a heating element [14]. The temperature of the ink around the heating element
increases and forces the ink out of the nozzle of the ink cartridge [14]. A piezoelectric
inkjet printer causes an electric charge to be applied to piezocrystals; subsequently, the
crystals vibrate and force a small amount of ink out of the nozzle of the cartridge [14].
There are several benefits to inkjet printers; specifically, they are relatively
inexpensive and do not contact the printing surface, thus limiting contamination [11, 14].
Printing patterns can be easily changed by simple modification of the corresponding
software [21]. Inkjet printing can also deliver a high density of cells and biomaterials
onto a substrate with little reduction in cellular viability [11, 22].
Bioprinters do have a few limitations, including concern that the heat and
mechanical stress in thermal inkjet printer can affect cell viability [14, 5, 21]. However,
several studies have shown that cells can still be viable with increases in temperature, and
many studies have shown the printing viability of a wide variety of cells such as breast
cancer cells and neural stem cells [5, 14, 11, 18, 21, 23]. Thorough cleaning of cartridge
reservoirs and nozzle clogging are major challenges to inkjet printing [24]. Parzel and
coworkers suggested that this nozzle clogging and failure is the result of salt scale buildup and aggregated cells on the printhead. Parzel and colleagues recommended
ethylenediaminetetraacetic acid (EDTA) to be used in bioink to help with the salt and cell
build up [25]. The cell viabilities in these preliminary studies were not substantially
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affected by the use of EDTA; however, more in depth studies must be conducted to
determine the limits of EDTA volumes and concentrations with respect to cell viability.
Inkjet bioprinting has great potential for use in the development of in vitro breast
tissue models [25-26]. A modified inkjet printer has been shown to be an inexpensive
way to build 3D in vitro models because the printer can easily be modified with high
throughput (8, 12,19).
Future of Bioprinting
Organ transplantation is a lifesaving procedure that has helped many with disease
conditions that were otherwise incurable [5, 14, 16]. However, as the need for more
organ donations goes up, the available number of organs remains the same [5, 14, 16].
The need for organ transplantation greatly surpasses the availability [27]. Organ
transplantation presents further complications due to tissue rejection, surgical
complications, and infections [14]. Tissue engineering and biofabrication have the great
potential to save many lives by replacing or restoring damaged tissue or organs, using the
patient’s own cells.
A long term goal of bioprinting is to create fully functional tissues and organs;
however, organ printing is still an idea of the future [5, 17]. Ideally, bioprinting
technology would be used to repair and replace damaged tissue or enhance the ability for
tissue to remodel [16]. Eventually bioprinting could facilitate the development of 3D
tissues that can be used in experiments or procedures, as well as tumor models for various
in vitro conditions [5, 18]. However, there are still many challenges to bioprinting,
including cell viability, pattern repeatability and accuracy, and sterility of printing; there
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is still a need for better biomaterials with the appropriate mechanical properties [5, 14].
Further technological improvements are needed for nozzle cartridge design, more
functional bioink with higher cell density, multiple bioinks, and better tissue maturation
processes [5,14]. There is also still some uncertainty on the level of cell damage that
bioprinting incurs; hence, additional studies to assess this point are needed [5]. Despite
current limitations, numerous studies are using bioprinting technology, and bioprinting
has great potential for tumor models, tissue grafts and even organ printing [14].
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CHAPTER TWO
INTERACTIONS BETWEEN CANCEROUS AND NONCANCEROUS BREAST
CELLS AFTER PRINTING IN LINES WITH BIOPRINTER

Introduction
Revolutionary medical techniques like organ transplantation and medical device
implantation are lifesaving procedures that have helped many with chronic and otherwise
incurable health conditions [5, 14, 16]. The lack of available organ donors and
complications due to tissue rejection, surgical complications, and infections are constant
barriers [14]. Tissue engineering and biofabrication have worked to combat these
obstacles by replacing or restoring damaged tissue or organs using the patient’s own
cells. Bioprinting is one promising application of biofabrication that involves the precise
arrangement of cells on a drop-by-drop basis to create scaffolds with more structural
integrity, organization, and complexity [16, 18]. Bioprinting has the potential for
enhanced damaged tissue repair or replacement, and eventually bioprinting could
accelerate the development of 3D tissues to be used in experiments, procedures, and
tumor models [5, 16, 18].
Inkjet printing technology has great promise for bioprinting. Inkjet printing can deliver a
precise pattern of cell and biomaterials in a controlled manner with little effect on the
samples [5, 19]. A modified inkjet printer has been shown to build 3D in vitro models
inexpensively and efficiently with high throughput [8, 12, 19]. Specifically, inkjet
bioprinting has great potential for development of in vitro breast tissue models [25-26].
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Though breast cancer death rates are decreasing, there is still a lack of understanding of
breast cancer development and metastasis, and therefore a need for cancer models that
mimic in vivo conditions. Though in vivo conditions are intricate and complex, many
cellular tissue models have a random arrangement of cells [18]. A model system with the
precise arrangement of cells would allow a better comprehension of cellular behavior and
intercellular signaling. Intercellular signaling is an essential aspect in complex biological
processes, and studying intercellular interactions gives a more thorough knowledge of
biological behavior [18]. Studies are needed to decipher the interactions of cancerous
and noncancerous cells to better understand cancer formation and development. The
objective of this study was to characterize the interactions of cancerous and noncancerous
breast cells through several qualitative and quantitative methods after the cells were
printed into lines of varying distances apart using a modified inkjet printer as a bioprinter.

Materials and Methods
MCF-10a human mammary gland epithelial cells and MCF-7 adenocarcinomic human
mammary gland epithelial cells were printed into sets of opposing lines of varying
distances apart using a modified inkjet printer. Three different sets of printed lines with
distances apart of 0

, 200

, and 800

were printed onto collagen- coated glass

slides. To assess the effect of the distance on printed lines of cancer and noncancerous
breast cells, an alamarBlue® assay, an immunofluorescent stain, a glucose and lactate
analysis, a Hoechst stain, and flow cytometry were employed. Samples were taken at
time points of Day 1 and Day 5 after printing to assess the effect of time on the printed
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lines. A baseline slide with opposing lines of MCF-10a cells and MCF-10a cells was
used as a comparison to the experimental slides, which had opposing lines of MCF-10a
cells and MCF-7 cells.
Cell Culture
MCF-10a human mammary gland epithelial cells and MCF-7 adenocarcinomic human
mammary gland epithelial cells (American Type Culture Collection (ATCC), Manassas,
VA) were cultured according to manufacturer recommendations. The MCF-10a cells
were cultured in a medium containing 500mL of Dulbecco’s Modified Eagle’s Medium
(DMEM) (DMEM, Atlanta Biologicals®, Lawrenceville, GA) supplemented with 50mL
of fetal bovine serum (FBS) (Corning, Manassas, NY), 5 mL of antibiotic-antimycotic
(AA) (Gibco, Great Island, NY), 1mL of fungizone (Gibco), 50

cholera toxin (Sigma,

St. Louis, MO), and Clonetics® MEGM® SingleQuots® (Lonza, Walkersville, MD).
The Clonetics® MEGM® SingleQuots® included 2mL bovine pituitary extract, 0.5mL
human epidermal growth factor, 0.5ml hydrocortisone, 0.5mL insulin, and 0.5mL
gentamicin. The MCF-7 cells were cultured in a medium containing 500mL of DMEM
supplemented with 50mL of FBS, 5 mL of AA, 1mL of fungizone, and 1.125mL of
insulin (Sigma, St. Louis, MO). The cells were first cultured in separate T-25 culture
flasks (Corning, Corning, NY), with the corresponding supplemented DMEM at 37ºC
and 5% CO2 in a CO2 incubator (Panasonic MCO-18ACL, Chicago, IL). The
corresponding culture medium was changed every 24 hours, and the cells were passaged
to a T-75 culture flask once 80% confluency was reached. All methods and procedures
were conducted in a biologic safety hood (SterilGARD III Advance, The Baker
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Company, Sanford, ME) with proper sterile technique. The solutions and components
were prepared with sterile components or were sterilized with a 0.22 µm filter (Corning,
Corning, NY) under vacuum.
Bioprinter
Printer Modification
The HP deskjet 340 inkjet printer (Hewlett-Packard Development Company, Palo
Alto, Ca) was modified for use as a bioprinter, as seen in Figure 2.1. The cover of the
printer was removed to expose the electronics and the cartridge feeder. The parts for the
paper feeder were removed, except for the motor controller of the paper feeder in order to
serve as an audio and visual alert to trigger the paper feeder. The entire printer was
mounted on top of a purple 6mm acrylic sheet (Altuglas International, Arkema Group,
Philadelphia, PA) cut from a Versa laser cutter (Laser & Sign Technology, Punchbowl,
Australia) and attached to two metal rods on the sides. A rectangular slit was removed
from the back of the printer to make room for a MMS micromanipulator stage (Unisense,
Aarhus, Denmark). The stage was controlled by a MC-232 motor controller (Unisense).
A platform was made from multiple layers of 6mm clear acrylic (Altuglas International)
glued together with superglue, and the acrylic platform was attached to the stage with
screws and nuts.
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Figure 2.1: Modified Bioprinter

Cartridge Modification
HP 26 cartridges (Hewlett-Packard Development Company, Palo Alto, Ca) were
used in conjunction with the bioprinter, as shown in Figure 2.2. The cartridges had 50
nozzles, each 80

in diameter, and a delivered a drop size of 140

, at 300 drops per

inch (dpi). The cartridges were modified to allow removal of the ink, cleaning of the
cartridges, and loading of bioink. To modify a cartridge, the white plastic plug at the top
of the cartridge was removed, and the ink was removed from the cartridge using a
vacuum. Two cuts, one horizontal and vertical, were made into the cartridge using a
band saw (Delta Power Equipment Corporation, Anderson County, SC) to remove the
front of the cartridge. The cartridge was rinsed with distilled water, and any plastic
debris was removed. The foil filter covering the reservoir above the printhead, and the
paper tab and the blue tab that covers the nozzles, were removed. The cartridge was then
rinsed with 70% ethanol (Pharmco-Aaper, Shelbyville, KY) to clean the firing chambers.
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Figure 2.2: Modified Ink Cartridge

Rubber Mask Modification
A rubber mask was constructed to seal to the collagen slide and provide a frame
around the printed lines in order to contain liquid on top of the printed lines, as seen in
Figure 2.3. Rectangles 8cm x 2.5cm in size were cut from a silicone rubber sheet (Fisher
Scientific, Pittsburgh, PA) using a Versa laser cutter; three squares, 13mm x 13mm in
size, were subsequently cut out of the rectangles to allow the three sets of prints.
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Figure 2.3: Rubber Mask

Software
The stage was controlled using Microsoft Visual Studio 2010 (Microsoft,
Redmond, WA); an example screenshot of the stage controller program can be seen in
Figure 2.4. The commands were sent using RS232 serial port to the motor controller, and
the commands were converted to the linear stage. Patterns were created in GIMP 2
(GNU Image Manipulation Program) as 300 x 900 pixel images, and then pasted into
Microsoft Word 2010 (Microsoft). The images were scaled to 2.54cm x 7.62 cm in
Microsoft Word so that each drop represented one pixel,and each image was the size of a
glass slide. The pattern was repeated in Microsoft Word, each line exactly one inch from
the next, to allow five prints on the same location. A total of four Microsoft Word
documents were created and used for each experiment. One document had a three-line
pattern, with the three lines evenly spaced apart representing the three squares in the
rubber mask. The other three documents each had an individual line that corresponded to
the left, middle, and right position of the three squares in the rubber mask.
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Figure 2.4: Stage Controller Program Software Screenshot

Cartridge Validation
Cartridges were validated the day of printing. The exterior of the nozzle head and the
connectors of the cartridge were cleaned with a Kimwipe (Kimberly-Clark Worldwide,
Inc, Irving Texas). The interior cylinder was filled with ink, and then the nozzle head was
wiped with a Kimwipe to allow the ink to flow. The exterior head of the nozzle was
checked for ink build up. If ink build up did occur, the cartridge was deemed likely
damaged and another cartridge was used. The cartridge was inserted into the cartridge
slot of the bioprinter by pushing the cartridge into the back bottom corner and then
rotating the cartridge back until it clicked into place. This process involved aligning the
connectors on the cartridge to the connectors on the slot. A rectangular piece of white
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paper was cut and placed over a slide, and the slide was loaded onto the platform. Once
the cartridge and slide were loaded, the stage controller was moved into position. A
validation document was opened in Word and set to print. The result stemming from each
cartridge was examined. The pattern was not always perfect, but the majority of the 50
pixels needed to be printed for the pattern to be deemed acceptable. The process was
repeated with each cartridge to assess whether a cartridge would be used or not.

Bioprinter Cleaning and Sterilization
Before and after printing, the bioprinter was cleaned with 70% ethanol with the
exception of the acrylic stage and the electronic parts. Prior to printing, the bioprinter
and the cartridges were placed in the biologic safety hood and UV sterilized for 10
minutes.

Cartridge Cleaning
After printing, the cartridges were washed with warm water and then distilled
water (MilliQ, Darmstadt, Germany). Each cartridge was placed into a beaker (Corning,
Corning, NY) with 100mL 70% ethanol, with the printhead submerged. While holding
the cartridge with two fingers, the 70% ethanol was removed with vacuumed, and the
cartridge was allowed to air dry.
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Preparation of Bioink
Once cells were about 80% confluent, the MCF-10a cells and MCF-7 cells were
trypsinized (Corning, Manassas, NY) and spun down. The MCF-7 cells were resuspended
in Dulbecco’s Phosphate Buffered Saline (PBS) (Sigma, St. Louis, MO) for a final
concentration of 2x106cells/mL. The MCF-10a cells were resuspended in PBS for a final
concentration of 8x106 cells/mL. To make the bioink, 150
150

of each cell mixture and

of ethylene diamine

tetraacetic acid (EDTA) (MP Biomedicals, LLC, Solon, OH) were mixed into a separate
1.5mL centrifuge tube (VWR, Radnor, PA).

Printing Cells Using the Bioprinter
Layout of Printing
The MCF-7 and MCF-10a cells were printed into opposing lines with the
modified bioprinter. Three different sets of printed lines 8mm in length with distances
apart of 0

, 200

, and 800

were printed onto a type I collagen coated glass slide

(Flexcell International Corporation, Burlington, NC). The layout of printing cells is the
same for all the testing methods except for the flow cytometry testing method. For all
methods except flow cytometry, a baseline slide involved printing the three-line pattern
with MCF-10a bioink, and then the three individual lines were printed with the MCF-10a
bioink. The experimental slide involved printing the three-line pattern with one cell type
bioink, and then the three individual lines were printed with the other cell type bioink.
The three individual lines (left, middle, right) for both the baseline and experimental
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slides were printed at 0

, 200

, and 800

distances apart from the lines in the

three-line pattern. The location (left, middle right) on the slide of the three distances
apart was randomized from slide to slide. For flow cytometry, all three sets of printed
lines are the same distances apart on each slide, but the distances apart vary from slide to
slide. The baseline slide involves printing the three-line pattern with MCF-10a bioink,
and then printing the second set of lines using the same three-line pattern with the MCF10a bioink but with the corresponding distance apart. The experimental slide involves
printing the 3 line pattern with one cell type bioink, and then printing the second set of
lines using the same 3 line pattern with the other cell type bioink but with the
corresponding distance apart. For each testing methods except flow cytometery, a total
of eight slides were used, including three experimental slides plus one baseline slides per
time point. For flow cytometry, a total of 24 slides were used, which includes nine
experimental slides plus three baseline slides per time point. Samples were taken at time
points day 1 and day 5 after printing. Each line printed consisted of a total of five passes.
Each drop from the cartridge delivered roughly one cell per drop, and with about 1000
drops per cell line, there was a total of 5,000 cells per cell line after five passes. Each
square on the slide represented about 10,000 cells per square.

Printing Procedure
A routine methodology was used to print a series of variable slides for each
testing method. The entire bioprinter was placed into a biologic safety hood for printing.
When ready to begin printing, the first collagen coated slide was placed onto the acrylic
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platform of the bioprinter as seen in Figure 2.5, and the corners were lightly taped down.
About 150
then 150

of the MCF-10a bioink was placed into the cylinder of one cartridge, and
of the MCF-7 bioink was placed into the cylinder of another cartridge. Since

the baseline slide was printed first, the cartridge with the MCF-10a bioink was inserted
into the bioprinter. The stage was loaded into position, and the three-line pattern in the
Microsoft Word document was sent to print with 5 passes. Then the stage was moved to
align for the 0

distance line, and one of the three individual lines was sent to print

five times. The stage was moved again to print the 200
finally, the stage was moved to print the 800

distance line five times and

distance line five times. Once the print

was complete, the slide was removed and placed in a petri dish (VWR, Radnor, PA) with
a lid. This process was repeated for the experimental slides except the cartridges with
different bioink were switched between the three-line pattern print and the three
individual line prints. The routine was performed for all of the slides in a way to
minimize cartridge switching and time.

19

Figure 2.5: Example of slide loaded onto platform for print

Post Bioprinting Procedure
After the cells were printed and placed in a petri dish, they were placed in the
incubator at 37ºC and 5% CO2 for 3 hours. After 3 hours, the rubber masks were applied
to the top of the slide and sealed around the printed line in order to contain liquid. Once
the rubber mask was firmly attached to the slide, 150

of MCF-10a media was added

to the each square of the rubber mask. The petri dishes containing the slide were placed
back into the incubator.

Analysis of Cellular Interaction
Hoechst Stain
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The printed cell lines were fixed with150

of 4% paraformaldehyde (Sigma,

St. Louis, MO) in each square for 30 minutes. Each square was rinsed with 150
PBS for 2 minutes. About 150

of

of Hoechst dye (Invitrogen, Eugene, OR) with a

concentration of 2mg/mL was added to each square. The petri dishes were covered with
tin foil and stored in a dark place for 15 minutes. After the 15 minutes, each square was
rinsed with 150

of PBS for 2 minutes. Slides were analyzed and images captured

using a Zeiss Axiovert 40 inverted fluorescent microscope (Carl Zeiss MicroImaging,
Gottingen, Germany).

YSI Glucose and Lactate Levels Analysis
The media added to each square on each slide was collected at Day 1 and Day5 in
1.5mL centrifuge tubes. The media was changed daily with each square washed with
150

of PBS before 150

of fresh MCF-10a media was added back to each square.

The media collected was analyzed using a YSI 2900 (YSI Life Sciences, Yellow Springs,
OH) for glucose and lactate levels. The experiment was run two times, and the results
were loaded into Microsoft Excel 2013 (Microsoft, Redmond, WA) worksheet. The
glucose and lactate levels were averaged and graphed in Microsoft Excel along with the
standard deviation. JMP 11 (SAS Institute Inc, Cary, NC) is a statistics program that
was used to perform an analysis of variance (ANOVA) statistical analysis on the data
collected from the YSI experiments.

alamarBlue® Assay

21

The alamarBlue® reagent (Invitrogen, Biosource International, Camarillo, CA)
was added to each square on, each slide at 10% of the culture medium. The slides were
then incubated for three hours at 37ºC and 5% CO2 in the incubator. After incubation, the
solution from each square was transferred to a 96 well plate (Corning, Corning, NY).
The samples were assessed using a Synergy 2 Multi-Mode spectrophotometer (BioTek,
Winooski, Vermont) with the absorbance measured at a wavelength of 570nm and
600nm. The experiment was run twice, and the results were loaded into a Microsoft Excel
(Microsoft) worksheet. The percent reduction was calculated using equation 1 and the
results were averaged and graphed in Microsoft Excel along with the standard deviation.
JMP was used to perform an ANOVA statistical analysis on the data collected from the
alamarBlue® experiments.

Equation 1: Calculation for percent reduction of alamarBlue® using absorbance
measurements at 570nm and 600nm

Immunofluorescence Staining
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The printed cells lines were fixed with150

of 4% paraformaldehyde in each

square for 30 minutes. Each square was rinsed with 150

of distilled H2O, PBS, and

0.2% Tween (Bio-Rad,Hercules, CA) in PBS for 2 minutes. About 150

of 5% goat

serum (Sigma Aldrich; St. Louis, MO) was added to each square and let sit for 30mins at
room temperature. A dilution of 1:50 of the primary antibody, E-cadherin (Pierce™
Thermo Scientific, Rockford, IL), was made in 5% goat serum. Each square was covered
with 150

of the primary antibody solution for 2 hours at room temperature. After two

hours, each square was rinsed with PBS for two minutes. A dilution of 1:100 of
secondary antibody (Alexafluor® 488 goat anti-mouse IgG H&L(Life Technologies,
Eugene, OR) was made in 5% goat serum. Each square was covered with 150

of the

secondary antibody solution, the petri dished were covered in tin foil and left in a dark
place overnight. Each square was rinsed with 150

of PBS and then H2O for 2

minutes. Slides were analyzed and images captured using a Zeiss Axiovert 40 inverted
fluorescent microscope.

Flow Cytometer Experiment
Each square was rinsed with 150
was washed with 150

PBS for 2 minutes, and then each square

of 1% goat serum. A dilution of 1:50 of the primary antibody,

E-cadherin, was made in 1% goat serum. Each square was covered with 150

of the

primary antibody solution for 30 minutes in a fridge. After 30 minutes, each square was
rinsed with 150

of 1% goat serum three times. A dilution of 1:100 of secondary

antibody was made in 1% goat serum. Each square was covered with 150
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of the

secondary antibody solution, and the petri dishes were covered in tin foil and left in a
fridge for 20 minutes. Each square was rinsed with 150

of 1% goat serum three times.

The rubber mask was then taken off and discarded. A Fisherbrand cell scraper (Fisher
Scientific, Pittsburg, PA) was used to scrape the collagen gel and the cells off the slide
into the petri dish. About 1mL of PBS was used to rinse the slide, cell scraper, and petri.
The mixture of PBS, collagen, and cells was collected into a 1.5mL micro centrifuge
tubes, and 10

of a 10% collagenase (StemCell Technologies Vancouver, Canada)

solution was added to each centrifuge tube. The centrifuge tubes were covered with tin
foil and placed in an incubator at 37ºC for 10 minutes. The centrifuge tubes were spun
down, the remaining liquid was removed, and the cells were resuspended in 400

of

4% paraformaldehyde for 15 minutes at room temperature covered with tin foil. The
centrifuge tubes were again spun down, the remaining liquid was removed, and the cells
were then resuspended in 200

PBS.

A separate collection of MCF-7 and MCF-10a cells not used for the bioprinter
were also used for the flow cytometer. Approximately 50,000 MCF-10a cells and 50,000
MCF-7 cells were placed separately into two 1.5mL micro centrifuge tubes for a total for
four centrifuge tubes. One MCF-10a and one MCF-7 centrifuge tube were rinsed with
150

of 1% goat serum. The two centrifuge tubes were spun down and the remaining

liquid was removed. The two centrifuge tubes were covered with 150

of the primary

antibody solution for 30 minutes in a fridge. After 30 minutes, each of the two tubes
were rinsed with 150

of 1% goat serum, spun down, and the remaining liquid was

removed. The two tubes were covered with 150
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of the secondary antibody solution,

covered in tin foil and left in a fridge for 20 minutes. After 20 minutes, each of the two
tubes were rinsed with 150

of 1% goat serum, spun down, and the remaining liquid

was removed. All four centrifuge tubes were resuspended in 400

of 4%

paraformaldehyde for 15 minutes at room temperature covered with tin foil. The
centrifuge tubes were again spun down, the remaining liquid was removed, and the cells
were then resuspended in 1mL of PBS.
All samples were then analyzed using a Millipore guava easyCyte single sample
flow cytometer (Millipore, Darmstadt, Germany). The results were loaded into a
Microsoft Excel worksheet, and the percent of stained green cells was averaged and
graphed in Microsoft Excel along with the standard deviation. JMP 11 was used to
perform an ANOVA statistical analysis on the data collected from the flow cytometry
experiments.

Statistical Analysis
JMP 11 was used to construct a one-way ANOVA statistical analysis for the data
collected in the YSI, alamarBlue®, and flow cytometer experiments. When formulating
a statistical analysis for the experimental data, several aspects needed to be considered
including the distance between the two printed cell lines (0

, 200

, and 800

),

the slide type (baseline or experimental slide), the day the experiment was run (day 1 or
day 5), which experimental run (run 1 or run 2), and which particular slide was used.
The ANOVA model was used to check for distal effects, slide type, and distal x slide type
effects. The ANOVA model included these effects in addition to a random “slide” effect
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for YSI and alamarBlue® experimental tests. The slide difference captured the day and
run differences.

Results
Hoechst Stain
A Hoechst stain was used to evaluate cell proliferaltion and the accuracy of
printed cell lines for the baseline and experimental slides for day 1 and day 5 after
printing. The images shown in Figures 2.6-2.8 are representative for the all the images
captured of the printed cell lines with the varying distances apart. The images for the
baseline slides showed a tendency to have a smaller population of cells especailly
compared to the day 1 and day 5 images (Figure 2.6). Even for the experimental slides,
the MCF-10a cells had a smaller popluation of cells compared to the MCF-7 cells, and
the MCF-7 cells usually clumped together (Figure 2.7-2.8). For both the baseline and
experimental slides, the printed cell lines usually had some overlap especially for the 0
μm and 200 μm distances apart (Figure 2.6-2.8).
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Figure 2.6: Hoechst stain for representative baseline slides with both printed cells lines
being MCF-10a cells (Scale bar = 1000μm). (A), (B), and (C) show printed cell lines at
day 1 after printing with lines at distances apart of 0 μm, 200 μm, and 800 μm
respectively. (D), (E), and (F) show printed cell lines at day 5 after printing with lines at
distances apart of 0 μm, 200 μm, and 800 μm respectively.
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Figure 2.7: Hoechst stain for representative experimental slides (Scale bar = 1000μm).
(A), (B), and (C) show printed cell lines at day 1 after printing with lines at distances
apart of 0 μm, 200 μm, and 800 μm respectively. The top cell line for (A), (B), and (C) is
MCF-10a and the bottom cell line is MCF-7.
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Figure 2.8: Hoechst stain for representative experimental slides (Scale bar = 1000μm).
(A), (B), and (C) show printed cell lines at day 5 after printing with lines at distances
apart of 0 μm, 200 μm, and 800 μm respectively. The top cell line for (A), (B), and (C) is
MCF-10a and the bottom cell line is MCF-7.
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YSI Glucose and Lactate Levels Analysis
A biochemical analysis for glucose and lactate levels was conducted for both the
baseline and experimental slide to measure the metabolic activity of the cells. The results
were averaged and graphed in Excel along with the standard deviation (Figure 2.9-2.10).

Figure 2.9: Biochemical analysis of glucose and lactate levels for baseline and
experimental slides at day1 after printing. The error bars represent the standard deviation
and column bars represent mean average of n=6 for experimental and n=2 for baseline.
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Figure 2.10: Biochemical analysis of glucose and lactate levels for baseline and
experimental slides at day5 after printing. The error bars represent the standard deviation
and column bars represent mean average of n=6 for experimental and n=2 for baseline.

A statistical analysis was run for the data collected from the YSI experiments, and
the data was graphed and analyzed using JMP 11 (Figure 2.11-2.12). Though the analysis
did not show a statistical difference between distances or slide type for glucose and
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lactate levels, there are some overall patterns from the collected data. When comparing
the data from day 1 and day 5, there was an overall increase in lactate and glucose levels
for both baseline and experimental slides. There were greater glucose and lactate levels
for experimental slide when compared to baseline slides. In general, the glucose and
lactate levels stay the same or slightly increase with increase of distance between the
lines.

Figure 2.11: Biochemical analysis of glucose levels at varying distances (0 μm, 200 μm,
and 800 μm) separated by slide type (baseline=1 or experimental =2) and day after
printing (day 1 or day 5) with a smooth trend line.
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Figure 2.12: Biochemical analysis of lactate levels at varying distances (0 μm, 200 μm,
and 800 μm) separated by slide type (baseline=1 or experimental =2) and day after
printing (day 1 or day 5) with a smooth trend line.

alamarBlue® Assay
A biochemical analysis using alamarBlue® levels was run for both the baseline
and experimental slides to measure the overall metabolic activity of the cells. The
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percent reduction in alamarBlue® for experimental and baseline slides was averaged, and
the results were graphed in Excel along with the standard deviation (Figure 2.13).

Figure 2.13: The percent reduction of alamarBlue® for baseline and experimental slides
at day1 and day 5 after printing. The error bars represent the standard deviation and
column bars represent mean average of n=6 for experimental and n=2 for baseline.
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A statistical analysis was run for the data collected from the alamarBlue®
experiments and the data was graphed and analyzed using JMP 11 (Figure 2.14). The
experimental slides were statistically different from the baseline slides with p<0.05. On
average, the experimental slides had a higher percent reduction in alamarBlue® than the
baseline slides for the corresponding distance. The change in the percent reduction in
alamarBlue® was also significantly different (p<0.05) for the varying distance between
the printed lines. On average, the percent reduction in alamarBlue® increased as the
distance between printed cell lines increased. However, the experimental slide for day 1
after printing decreased with increase in distance between lines on average (Figure 2.14).
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Figure 2.14: The percent reduction of alamarBlue® for baseline and experimental slides
at varying distances (0 μm, 200 μm, and 800 μm) separated by slide type (baseline=1 or
experimental =2) and day after printing (day 1 or day 5) with a smooth trend line.
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Immunofluorescence Staining
A green immunoflourescence stain for E-cadherin was used to evaluate cell
proliferaltion and migration of the printed cells line for the baseline and experimental
slides for day 1 and day 5 after printing. The images shown in Figure 2.15-2.16 are
representative for the all the images captured of the printed cell lines with the varying
distances apart. The images for the baseline slides showed little to no green flourecence
(Figure 2.15). The experimental slides showed green flourescence for the MCF-7 cell
lines, but little to no green flourescence for MCF-10a cells (Figure 2.16). The green
flourescence didn’t change when comparing day 1 and day 5 images for both baseline
and experimental slides.
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Figure 2.15: E-cadherin stain for representative baseline slides at day 1 after printing
(Scale bar = 1000μm). (A), (B), and (C) represents E-cadherin stain with printed cell
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lines at distances apart of 0 μm, 200 μm, and 800 μm respectively. (D), (E), and (F) are
the same E-cadherin stain overlaid with a Hoechst stain.
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Figure 2.16: E-cadherin stain for representative experimental slides at day 1 after
printing. (Scale bar = 1000μm). (A), (B), and (C) represents E-cadherin stain with
printed cell lines at distances apart of 0 μm, 200 μm, and 800 μm respectively. (D), (E),
and (F) are the same E-cadherin stain overlaid with a Hoechst stain.
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Flow Cytometer Experiment
The flow cytometer was used to count the number of cells with the green
immunofluorescence stain for E-cadherin after printing in lines. The flow cytometer
calculated the percentage of green cells found for the baseline and experimental slides for
each varying distance at day 1 and day 5 after printing. The results were averaged and
graphed in Excel along with the standard deviation (Figure 2.17). MCF-7 and MCF-10a
cells not used by the bioprinter were also counted in the flow cytometer as a comparison
for the cells collected from the baseline and experimental slides (Table 2.1).

Table 2.1: Number and percentage of green stained and not stained cells collected as a
comparison to cells collected from experimental and baseline slides
Total Cell

Green Cell

Percentage of Green

Count

Count

Cells (%)

2991

59

1.97

Stained

1002

144

14.37

MCF-7 Stained

2867

2040

71.15

MCF-10a Stained

3772

3201

84.86

Cell Type

MCF-7 Not Stained
MCF-10a Not
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Figure 2.17: The percentage of green cells stained with E-cadherin for baseline and
experimental slides at day1 and day 5 after printing. The error bars represent the standard
deviation and column bars represent mean average of n=3.

A statistical analysis was conducted for the data collected from the flow
cytometer experiments, and the data was graphed and analyzed using JMP 11 (Figure
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2.18). The experimental slides were statistically different from the baseline slides with
p<0.05. On average, the baseline slides had a higher percentage of green cells than the
experimental slides for the corresponding distance. The change in the percentage of
green cells was not significantly different (p<0.05) for the varying distance between the
printed lines. The baseline and experimental slides followed the same general pattern
when comparing day 1 and day 5. The baseline and experimental slide increase
percentage of green cells with increase in distance between lines for day 1, but decrease
in percentage of green cells with increase in distance between lines for day 5.
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Figure 2.18: The percentage of green cells for baseline and experimental slides at varying
distances (0 μm, 200 μm, and 800 μm) separated by slide type (baseline=1 or
experimental =2) and day after printing (day 1 or day 5) with a smooth trend line. The
green immunoflourescence stain was for E-cadherin.
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Discussion
The objective of this research was to examine the effect of distance on cancerous
and noncancerous breast cells after printing into opposing lines using a bioprinter.
Numerous aspects of this study had to be considered to form a quality experimental
design with relevant practical analyses. The abilities and limitations of the bioprinter and
ink cartridges, the type of cells, the substrate for printing cells, the overall design of the
experiment and the experimental analyses were taken into account when setting
developing this study.
Limitations of the bioprinter affected several experimental design choices. The
height of the cartridge above the printing substrate was constrained due to pattern
retention. The best pattern retention placed the cartridge within 1cm of the printing
substrate. The further away from the printing substrate, the more splatter from the bioink
and less pattern retention. With the height restriction, the printing surface was
constrained. Slides offered the best option for pattern retention because the cartridge
could come very close to the printing surface. Though slides were great for pattern
retention, slides could not retain any media after printing. Rubber masks were chosen as
the best solution because they could be applied after printing and retain media to its
defined square. However, if the rubber mask did not seal properly, there was leakage onto
other parts of the slide. The cartridges themselves were not always consistent and had a
narrow time capacity for printing. If the cells were sitting in the cartridges for too long,
the cartridges would become clogged and unable to print. The bioink was loaded
immediately before printing, and the cartridges were often switched out after 4 to 5 slides
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were printed. The understanding of these bioprinter limitations facilitated a better
examination of the research question.
MCF-7 cells, non-invasive human breast cancer cells, were used in this model as
cancerous cells, and MCF-10a, non-transformed breast cells, were used in this model as
normal, noncancerous cells [28]. MCF-10a and MCF-7 cells grow cobblestone
morphologies and maintain their normal cell-cell adhesion on most ECM [10]. Multiple
printing substrates were considered including collagen type I, a collagen-agarose mixture,
and agarose based on the prevalence for in vitro models though each gel has advantages
and disadvantages for tissue test systems [12-13, 20, 29-30, 31]. Based on preliminary
studies, collagen type I was chosen as the best printing surface because the cells stuck to
the collagen while still keeping the pattern intact. The mixture of collagen and agarose
and the pure agarose gel did not provide an adequate environment for the cells to attach,
and the cells would almost immediately run off the substrate after printing.
Collagen type I is the most abundant molecule found in the ECM in normal and
malignant mammary tissue, and therefore is often used in tissues models [10, 13, 29, 32].
Collagen has the right surface for cell adhesion and migration and has good
biocompatibility and mechanical strength [31, 33]. Cells can quickly remodel collagen,
and the initial structure of the collagen can quickly change in culture [12, 30, 32]. Despite
drawbacks, collagen provided an adequate environment for the testing of the research
question. A collagen coated slide was chosen for a consistent surface as well as perfectly
flat printing area, which was crucial for pattern retention.
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The experimental model for this project was set up using literature as well as
preliminary studies. The time points, day 1 and day 5, were chosen based on the previous
studies for cell viability in a 2-D environment, and the adequate amount of time for the
cells to communicate [ 31, 34]. After day 5, the MCF-7 and MCF10a decreased in
proliferation [31, 34]. The distances were chosen based on the general distance for a
single cell to effectively communicate, which is about 250 μm [35]. The three distances
represent touching distance (0 μm), a short distance where they can still communicate
(200 μm), and a distance where the cells can theoretically not communicate (800 μm)
[34, 35].
The testing analyses were chosen based on the informative nature and
compatibility with the bioprinter project and were intended to portray a general picture of
the cellular activity after printing the cells into lines. The Hoechst stain was used a visual
examination of the printed cellular lines. There is a degree of overlap between the lines
for the distances 0μm and 200μm as seen in Figures 2.6-2.89, but there is almost no
overlapping of lines for distance 800μm. This implies the cells could definitely
communicate at 0μm and probably communicate at 200μm, but possibly not
communicate at distance 800μm. The MCF-10a cells lines are less dense from day 1 to
day 5 (Figure 2.6), which might indicate poor MCF-10a attachment and MCF-10a cell
death at day 5. The MCF-10a cells did not attach to the collagen as fast as the MCF-7
cells, which is why the slides were incubated for three hours before adding media. The
MCF-7 cells printed in clumps of cells rather than more individual cells like the MCF10a cells (Figure 2.7-2.8).
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The analysis of the glucose and lactate levels demonstrated the metabolic activity
of the MCF-7 and MCF-10a cells, which provided insight into the growth of cells. For
normal cellular metabolic activity, cells uptake glucose and produce lactate causing
glucose levels to decrease while lactate levels increase over time. From the collected
data, there was no statistical difference of the glucose and lactate levels between the
varied distances for both experimental and baseline slides. There was no statistical
difference between the glucose and lactate levels for the baseline and experimental slides,
which implies the MCF-7 cells did not affect the metabolic activity of the MCF-10a cells.
However, there was an overall increase in both glucose and lactate levels from day 1 to
day 5. The overall increase in glucose and lactate levels from day 1 to day 5 could be due
to residual glucose left even after each square was washed with PBS and the media
changed. The overall increase in lactate levels could also suggest the cellular growth for
both baseline and experimental slides.
The alamarBlue® is assay is a quantitative analysis to establish the overall health
of the cell by measuring the metabolic activity [36]. The assay utilizes an oxidationreduction indicator that changes color with the reduction of growth media that results
from cellular growth. As the cells grow, the metabolic activity of the cell takes up the
media and results in a reduction of alamarBlue® [36]. A higher reduction of
alamarBlue® suggests more metabolic activity and therefore more cellular growth. The
experimental slides were statistically different than the baseline slide (p<0.05) with the
experimental slides having a higher percent reduction than the baseline slides. This could
be due to the MCF-7 cells growing much faster than the MCF-10a cells. The change in
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distance between the slide also was statistically different for the experimental and
baseline slide (p<0.05) with the increase in distance causing the increase percent
reduction of alamarBlue®. This could suggest that the distance between the lines does
have an effect on the cells particularly for day 5 rather than day 1 after printing (Figure
2.14).
Both the MCF-7 and MCF-10a cells express the protein E-cadherin, and this
expression can be used for many testing methods [10, 37]. Both the immunofluorescence
stain and the flow cytometry analysis utilize the E-cadherin expression in MCF-10a and
MCF-7 cells. E-cadherin is a transmembrane protein that plays an important role to
many characteristics of epithelial cells, and studies have shown that intercellular
interactions between normal and cancerous cells involve E-cadherin [37-39]. E-cadherin
loss or downregulation is associated with the breakage of cell-cell adhesion, which leads
to epithelial-mesenchymal transition (EMT) and eventually cancer metastasis [31, 39, 38,
40]. EMT is considered one of the first mechanisms to breast cancer progression because
cells lose cell-cell adhesion and become mobile [38-39]. A higher E-cadherin expression
means a lower ability to move.
The immunofluorescence stain seen in Figures 2.15 shows the MCF-10a cells
with little to no green fluorescence. The MCF-7 cells show sizable green fluorescence,
and the MCF-10a cells show slightly more green fluorescence in Figure 2.16. Time does
not seem to affect the immunofluorescence stain since the day 1 and day 5 pictures did
not show any difference. Trypsin has been noted to immediately lower E-cadherin
expression for MCF-10a and MCF-7 because E-cadherin is degraded, but E-cadherin
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expression was gained back over time [37]. Trypsin should not have modified the Ecadherin expression because the samples were taken 24 hours after printing when Ecadherin expression should have been gained back.
The baseline slides were statistically different from the experimental slides for the
flow cytometer experiment. From Table 2.1, the not stained MCF-10a cells showed a
high percentage of 14.37% of green fluorescence while the not stained MCF-7 cells
showed only 1.97% green fluorescence. Stained MCF-7 and MCF-10a cells showed the
same 12 percentage difference with the stained MCF-7 cells showing 14.37% and the
stained MCF-10a cells showing 84.86% (Table 2.1). This could explain why the baseline
slides had a much higher percentage of green fluorescing cells than the experimental
slides (Figure 2.18). There was a general pattern when comparing day 1 and day 5 slides.
The baseline and experimental slide increase percentage of green cells with increase in
distance between lines for day 1, but decrease in percentage of green cells with increase
in distance between lines for day 5. This could suggest that E-cadherin expression is
affected by the interactions of MCF-7 and MCF-10a cells, and the distance between the
cells causes a change in expression.

Conclusion
The results from the collected data of experimental analyses are inconclusive but
do point towards several general findings. When comparing performance of the baseline
and experimental slides, it appears the cancerous MCF-7 cells modify the cellular
behavior of the noncancerous MCF-10a cells. Time does play a key role in the activities
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of the cells, particularly for metabolic activity as the results differ from day 1 to day 5.
The overall results also point toward a change in cellular behavior with a change in
distance.
More studies need to be conducted in order to achieve more conclusive outcomes.
Several improvements or alterations could be made to achieve more decisive findings.
The printing substrate and media retention solution presented limitations for experimental
analyses and could have affected the outcome of the findings. A printing surface with
allowing for better cellular communication might enhance the investigation. The
accuracy of the cartridge greatly hindered several studies, and a better solution to
cleaning and storage of the cartridge might help facilitate pattern retention. The study
laid the foundation for future research to use a bioprinter to measure the effect of distance
on cancerous and noncancerous cells. Future studies should focus on improvements or
alterations to the bioprinter and experimental analyses to enhance findings.
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